Select a community
ALS including PLS and PMA
Find out more about the PatientsLikeMe
ALS Community
Home > Community Treatment Reports > Levodopa-Benserazide Treatment Report
What is Levodopa-Benserazide?

Levodopa is the precursor molecule to dopamine, an important neurotransmitter implicated in the underlying cause of Parkinson's disease. Benserazide is an additive which allows the levodopa to continue circulating in the body for longer.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Stiffness/Spasticity 1 1

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
1 100%
Mild
0 0%
None
0 0%

Most commonly reported side effects

sickness
1 100%
  • Mild
  • Moderate
  • Severe

Stop Reasons

Why Patients Stopped Taking Levodopa-Benserazide (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
1 100% Did not seem to work: 100%

See all 1 patient who’ve stopped taking Levodopa-Benserazide

Duration See details about how long patients take this treatment ▼

Stopped Taking Levodopa-Benserazide

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
1 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
1 100%
A little
0 0%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

Report created on November 22, 2009.